Theratechnologies discovers temasorelin may improve metabolic syndrome in people with HIV
A synthetic peptide analogue developed by Theratechnologies Inc. helps to reduce excess visceral abdominal fat (EVAF) in people with HIV.
Archives for February 23, 2023
ObvioHealth reveals new multitasking digital therapeutics API
With the ongoing digital shift in clinical trials, companies are continuously striving to improve both patient experience and clinical data quality.
Viiv Healthcare gets European Marketing Authorisation for children's HIV drug
Children in Europe living with HIV are on course to receive a once-daily treatment after EU marketing authorisation (EMA) was given to ViiV Healthcare’s Triumeq PD.